Previous 10 | Next 10 |
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you can re...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. No formal trade talks are scheduled between the U.S. and China, but President Trump...
WALTHAM, Mass., May 20, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced the company will be participating in the upcoming Guggenheim MedTech Disruptors Summit in New York, NY. Avedro’s management is scheduled to present on Wednesday...
Avedro (NASDAQ: AVDR ): Q1 GAAP EPS of -$1.00 beats by $0.01 . More news on: Avedro, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
WALTHAM, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro) today reported financial results for the quarter ended March 31, 2019. Recent Highlights First quarter 2019 revenue of $8.8 million – an increase of 70% year over year Gross margin increase...
Last year was a record year for biotech stocks, with an impressive number of companies going public and raising a significant amount of money in the space. In fact, in 2018 there were 80 biotech IPOs that raised a record total of $8.65 billion in gross proceeds. This trend is continuing...
WALTHAM, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro), today announced that the company has completed patient enrollment in a pivotal Phase 3 clinical trial to evaluate the safety and efficacy of an epithelium-on (Epi-On) corneal cross-linking procedure for...
WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced the company will be participating in the upcoming Bank of America Merrill Lynch Health Care conference in Las Vegas, NV. Avedro’s management is scheduled to p...
WALTHAM, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc . (Nasdaq: AVDR) (Avedro) today announced the inclusion of a wide range of corneal cross-linking and keratoconus scientific and educational programs at the 2019 American Society of Cataract and Refractive Surgery (ASCRS) Annu...
WALTHAM, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”) today announced that it will release financial results for the first quarter of 2019 after the close of trading on Thursday, May 9, 2019. Avedro’s management team will host a corre...
News, Short Squeeze, Breakout and More Instantly...
AVDR US LargeCap Leading ETF Company Name:
AVDR Stock Symbol:
NYSE Market:
AVDR US LargeCap Leading ETF Website:
New Age Alpha Trust announced today the impending closure and liquidation of the AVDR US LargeCap Leading ETF (CBOE: AVDR) and the AVDR US LargeCap ESG ETF (CBOE: AVDG). The New Age Alpha Trust Board of Trustees approved the closing and subsequent liquidation of AVDR and AVDG. Each Fund...
SAN DIEGO, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for investors who formerly held Avedro, Inc. (Nasdaq: AVDR) shares. Investors, who held shares of Avedro, Inc. (AVDR) and received Glaukos Corporation (NYSE: GKOS) shares as ...
WALTHAM, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro), today reported financial results for the quarter ended September 30, 2019. Third Quarter Financial Results Revenue for the quarter ended September 30, 2019 increased 38% to $11.0 million, from $8.0 ...